Allspring Global Investments Holdings LLC cut its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 4.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,181 shares of the real estate investment trust’s stock after selling 841 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Sabra Healthcare REIT were worth $296,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of SBRA. State of Michigan Retirement System boosted its position in Sabra Healthcare REIT by 1.1% during the first quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust’s stock worth $990,000 after purchasing an additional 600 shares in the last quarter. Louisiana State Employees Retirement System boosted its position in Sabra Healthcare REIT by 0.9% during the first quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust’s stock worth $1,158,000 after purchasing an additional 600 shares in the last quarter. Diversify Advisory Services LLC boosted its position in Sabra Healthcare REIT by 5.7% during the first quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust’s stock worth $226,000 after purchasing an additional 689 shares in the last quarter. IFP Advisors Inc boosted its position in Sabra Healthcare REIT by 16.2% during the first quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust’s stock worth $88,000 after purchasing an additional 706 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. boosted its position in Sabra Healthcare REIT by 4.7% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust’s stock worth $331,000 after purchasing an additional 853 shares in the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms have recently weighed in on SBRA. Wells Fargo & Company cut their price target on Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating for the company in a report on Tuesday. National Bankshares set a $22.00 target price on Sabra Healthcare REIT in a research note on Friday, October 17th. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Saturday. BMO Capital Markets upped their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a research note on Monday, August 25th. Finally, JMP Securities upped their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $20.75.
Sabra Healthcare REIT Trading Down 0.7%
Shares of NASDAQ SBRA opened at $18.08 on Friday. The stock’s 50 day moving average price is $18.65 and its two-hundred day moving average price is $18.23. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03. The stock has a market capitalization of $4.34 billion, a P/E ratio of 23.79, a PEG ratio of 1.15 and a beta of 0.85. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million for the quarter, compared to analysts’ expectations of $185.64 million. During the same period in the prior year, the firm earned $0.36 EPS. The business’s quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.6%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 157.89%.
Sabra Healthcare REIT Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Read More
- Five stocks we like better than Sabra Healthcare REIT
- NYSE Stocks Give Investors a Variety of Quality Options
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- How to buy stock: A step-by-step guide for beginners
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
